Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New crisis therapy aims to curb suicidal thoughts

NCT ID NCT05638204

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new short-term treatment called Suicidal Crisis Intervention (SCI) for adults who have attempted suicide or are in a suicidal crisis. The goal is to reduce suicidal thoughts and related feelings like hopelessness. About 390 participants will be randomly assigned to receive SCI or standard care, and researchers will track changes over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 390 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2023

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Patient: * After a suicide attempt or suicidal crisis * ≥ 18 years * Availability of a smartphone, tablet and/or computer with internet access, * Dutch-speaking. Exclusion Criteria Patient: * Limited comprehension, cognitive impairment * Psychotic disorder * Unsuitable for individual therapy * Receiving other forms of care is not an exclusion criterion. Inclusion Criteria Close one: * close one of the patient * ≥ 18 years * Dutch- speaking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal ideation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Groeninge (incl. Mobiel Crisis Team Kortrijk)

    RECRUITING

    Kortrijk, Belgium

  • Algemeen Ziekenhuis Glorieux

    RECRUITING

    Ronse, Belgium

  • Bethanië GGZ (incl. mobiel crisis team SARA Het Veer)

    RECRUITING

    Zoersel, Belgium

  • Medisch Centrum St. Jozef

    RECRUITING

    Bilzen, Belgium

  • Mobiel Crisis Team zorggroep Multiversum

    RECRUITING

    Boechout, Belgium

  • Openbaar Psychiatrisch Zorgcentrum Geel

    RECRUITING

    Geel, Belgium

  • Openbaar Psychiatrisch Zorgcentrum Rekem

    RECRUITING

    Rekem, Belgium

  • Psychiatrisch Centrum Ariadne

    RECRUITING

    Lede, Belgium

  • Psychiatrisch Centrum Sint Amandus (incl. Mobiel Crisis Team)

    RECRUITING

    Beernem, Belgium

  • Psychiatrisch Ziekenhuis Heilige Familie Kortrijk

    RECRUITING

    Kortrijk, Belgium

  • Psychiatrisch Ziekenhuis Sint Lucia (incl. Mobiel Team Acute Zorgen)

    RECRUITING

    Sint-Niklaas, Belgium

  • UZ Gent

    RECRUITING

    Ghent, 9000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.